Tuesday, November 29, 2005

Tamiflu and Rumsfeld, too

This is just too much to be believed. I thought that our public servants were supposed to divest themselves of assets when they joined the Administration. (Of course Bill "Lookin more like Martha everyday" Frist is an exception):
NEW YORK (Fortune) - The prospect of a bird flu outbreak may be panicking people around the globe, but it's proving to be very good news for Defense Secretary Donald Rumsfeld and other politically connected investors in Gilead Sciences, the California biotech company that owns the rights to Tamiflu, the influenza remedy that's now the most-sought after drug in the world. Rumsfeld served as Gilead (Research)'s chairman from 1997 until he joined the Bush administration in 2001, and he still holds a Gilead stake valued at between $5 million and $25 million, according to federal financial disclosures filed by Rumsfeld.

The forms don't reveal the exact number of shares Rumsfeld owns, but in the past six months fears of a pandemic and the ensuing scramble for Tamiflu have sent Gilead's stock from $35 to $47. That's made the Pentagon chief, already one of the wealthiest members of the Bush cabinet, at least $1 million richer. (emphasis added)
The ensuing scramble for Tamiflu was in large part fueled by dear King George's announcement that we would stockpile it. So there, America. Take that.

They may not be able to govern Iraq, but they sure do know how to make money. (Usually dishonestly). And, least you think its confined to George the present, George the first's administration is not exempt:
Former Secretary of State George Shultz, who is on Gilead's board, has sold more than $7 million worth of Gilead since the beginning of 2005.
A fish rots from its head.
What's more, the federal government is emerging as one of the world's biggest customers for Tamiflu. In July, the Pentagon ordered $58 million worth of the treatment for U.S. troops around the world, and Congress is considering a multi-billion dollar purchase. Roche expects 2005 sales for Tamiflu to be about $1 billion, compared with $258 million in 2004.

No comments: